VGF
Basic information
Region (hg38): 7:101162509-101165569
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VGF gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 49 | 51 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 49 | 5 | 4 |
Variants in VGF
This is a list of pathogenic ClinVar variants found in the VGF region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-101163121-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
7-101163150-T-C | not specified | Uncertain significance (Sep 14, 2022) | ||
7-101163186-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
7-101163201-T-C | not specified | Uncertain significance (Oct 07, 2022) | ||
7-101163242-C-G | not specified | Uncertain significance (Jul 12, 2023) | ||
7-101163253-C-A | not specified | Uncertain significance (Jul 14, 2023) | ||
7-101163280-C-A | not specified | Uncertain significance (Jul 25, 2023) | ||
7-101163289-C-T | not specified | Uncertain significance (Sep 26, 2023) | ||
7-101163294-C-A | not specified | Uncertain significance (Jun 21, 2022) | ||
7-101163309-G-A | not specified | Uncertain significance (Dec 28, 2023) | ||
7-101163318-G-A | not specified | Uncertain significance (Dec 07, 2023) | ||
7-101163321-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
7-101163336-A-G | not specified | Uncertain significance (Jan 03, 2024) | ||
7-101163358-C-A | not specified | Uncertain significance (Mar 07, 2024) | ||
7-101163363-G-T | not specified | Uncertain significance (Jun 02, 2023) | ||
7-101163366-G-C | not specified | Uncertain significance (May 31, 2024) | ||
7-101163366-G-T | not specified | Uncertain significance (Aug 01, 2023) | ||
7-101163368-C-G | Benign/Likely benign (May 01, 2022) | |||
7-101163376-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
7-101163518-C-G | not specified | Likely benign (Jan 04, 2022) | ||
7-101163542-C-G | Likely benign (Nov 14, 2018) | |||
7-101163558-C-T | not specified | Uncertain significance (Jan 05, 2022) | ||
7-101163561-C-G | not specified | Uncertain significance (Jul 20, 2022) | ||
7-101163561-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
7-101163565-G-A | not specified | Uncertain significance (Mar 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VGF | protein_coding | protein_coding | ENST00000249330 | 1 | 3085 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.568 | 0.431 | 121942 | 0 | 2 | 121944 | 0.00000820 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.251 | 316 | 329 | 0.961 | 0.0000152 | 3814 |
Missense in Polyphen | 94 | 102.33 | 0.91862 | 1212 | ||
Synonymous | -1.27 | 174 | 154 | 1.13 | 0.00000759 | 1345 |
Loss of Function | 2.94 | 3 | 15.5 | 0.193 | 6.83e-7 | 185 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000156 | 0.000126 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in the regulation of cell-cell interactions or in synatogenesis during the maturation of the nervous system. {ECO:0000250}.; FUNCTION: Antimicrobial peptide VGF[554-577]: Has bactericidal activity against M. luteus, and antifungal activity against P. Pastoris. {ECO:0000269|PubMed:23250050}.;
- Pathway
- Post-translational protein phosphorylation;Post-translational protein modification;Metabolism of proteins;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
(Consensus)
Recessive Scores
- pRec
- 0.194
Haploinsufficiency Scores
- pHI
- 0.380
- hipred
- Y
- hipred_score
- 0.622
- ghis
- 0.476
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.417
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vgf
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- ovarian follicle development;response to dietary excess;generation of precursor metabolites and energy;response to cold;regulation of signaling receptor activity;sexual reproduction;insulin secretion;response to insulin;glucose homeostasis;defense response to bacterium;post-translational protein modification;cellular protein metabolic process;response to cAMP
- Cellular component
- extracellular space;endoplasmic reticulum lumen;Golgi apparatus;transport vesicle;cytoplasmic vesicle;intracellular membrane-bounded organelle
- Molecular function
- molecular_function;neuropeptide hormone activity;growth factor activity